Experts
    • Interventional Cardiology
    • Associate Professor of Cardiology at University of Catania
    Davide Capodanno, MD, PhD is Associate Professor of Cardiology at the University of Catania and Interventional Cardiologist at Ferrarotto Hospital, Azienda “Policlinico-Vittorio Emanuele” in Catania, Italy. He received his MD and PhD from the University of Catania and completed his research fellowship at the University of Florida in Jacksonville, FL. The recipient of six Investigator Awards for cardiology research, including the "Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award" from the Cardiovascular Research Foundation in 2011, Dr. Capodanno has authored more than 250 manuscripts published in the peer-reviewed literature as well as numerous book chapters, and has delivered more than 100 invited lectures around the world. Dr. Capodanno’s areas of expertise include drug-eluting stents, bioresorbable scaffolds, left main, thrombosis and haemostasis, antiplatelet and antithrombotic pharmacotherapies, clinical trial design and biostatistics. Dr. Capodanno is the Chair of the New Initiatives for Young Interventionalists of the European Association of Percutaneous Coronary Intervention (EAPCI), and the Co-Director or Associate Director of multiple Courses, including the EAPCI Fellows Course, the PCR Clinical Research Course and TCT. He is a member of the Working Group Thrombosis of the European Society of Cardiology and a Program Committee member of EuroPCR. Dr. Capodanno is peer reviewer of 20 international journals, including Lancet, JACC, Circulation and the European Heart Journal, a member of the International Editorial board of the European Heart Journal, and an Associate Editor of Eurointervention.
    • Clinical Pathology
    • President and Medical Director at CVPath Institute
    Renu Virmani, MD, received her doctorate from Lady Hardinge Medical College at Delhi University in New Delhi, India, in 1973. She completed her residency at George Washington University Medical Center in 1977 and a fellowship at the National Heart, Lung, and Blood Institute in 1979. Virmani became medical director of CVPath of the International Registry of Pathology in 2005. Virmani is also a clinical professor at the University of Maryland in Baltimore, the Uniform University of Health Sciences in Bethesda, Md., and George Washington University. She is a clinical research professor at Vanderbilt University in Nashville. Virmani has served on the editorial boards and review boards of numerous publications including Circulation, Journal of the American College of Cardiology, American Journal of Cardiology, Human Pathology and Modern Pathology. Her work has been published in New England Journal of Medicine, Circulation, Journal of Vascular Surgery, Journal of the American Medical Association and many other scholarly publications.
    • Interventional Cardiology
    Interventional Cardiologist at the University Hospital Clinic, Barcelona, Spain
    Interventional Cardiologist at the University Hospital Clinic, Barcelona, Spain
    • Interventional Cardiologist at University Clinic Hospital
    Salvatore Brugaletta, MD, PhD, FESC is interventional cardiologist at the University Clinic Hospital and researcher of the IDIBAPS (Institut d’investigacions biomediques August Pi I Sunyer) in Barcelona, Spain. Dr. Brugaletta received his medical and cardiology degrees at the Catholic University of the Sacred Heart in Rome, Italy, under the supervision of prof. Filippo Crea. He served as fellow in interventional cardiology at the University Saint Paul Hospital in Barcelona, Spain, under the supervision of prof. Manel Sabate. Dr. Brugaletta completed two PhD, one in molecular and cellular cardiology at the Catholic University of the Sacred Heart in Rome, Italy, and one in intracoronary imaging techniques and in bioresorbable scaffolds at the Erasmus University in Rotterdam, the Netherlands, under the supervision of prof. Patrick W. Serruys. He authored more than 200 manuscripts and abstracts published in the peer-reviewed literature as well as various book chapters and has delivered many invited lectures in national and international congresses. He has received numerous awards and grants from national and international cardiology societies. Dr. Brugaletta’s area of expertise include interventional therapy of coronary artery disease, especially acute coronary syndromes, drug-eluting stents and bioresorbable scaffolds, intravascular imaging techniques (IVUS, VH, OCT, NIRS, echogenicity), antiplatelet and antithrombotic agents, vulnerable plaque diagnosis and treatment, endothelial function assessment and clinical trial design.
    • Interventional Cardiology
    • Professor for Translational Vascular Medicine at University Medical Center Mainz
    Tommaso Gori is Professor for translational vascular medicine at the University Medical Center of Mainz, Germany where he also leads the Cardiac Catheterization Laboratory and the Clinical Study Center. He obtained his title of Dottore in Medicina e Chirurgia (MD equivalent) from the University of Siena, Italy, and his PhD from the University of Toronto, Canada. He has worked in Siena, Italy (Department of Medicine II, Director Prof S Forconi), Toronto, Canada (Mount Sinai Hospital, Director Prof JD Parker) and Mainz, Germany (Department of Medicine II, Director Prof T Münzel). Dr Gori was winner of 19 international awards, among which the American Heart Association – S.A. Levine Young Investigator Award and the Young Investigator Award of the American College of Cardiology, both in the year 2001. Dr Gori has authored 185 peer-reviewed papers in the fields of endothelial (dys)function, mechanisms of action and effects of organic nitrates, physiology of the coronary circulation, oxidative stress, ischemic preconditioning, microcirculation and hemorheology and interventional cardiology. Dr Gori´s areas of clinical expertise include structural, peripheral and coronary interventions and imaging modalities with a particular focus on coronary scaffolds.
    • Interventional Cardiology
    • Professor of Medicine at University California, Irvine
    Dr. Kern completed undergraduate education at UCLA, medical school and medical residency at Mt. Sinai School of Medicine and Hospital, NYC and cardiology fellowship training at the Brigham and Women’s Hospital at Harvard, Boston, Massachusetts. Dr. Kern is currently Professor of Medicine, Chief of Medicine at the Long Beach Veterans Administration Hospital and continues as a member of the Division of Cardiology, University California Irvine. Dr. Kern, formerly Professor of Medicine and Director of the prestigious JG Mudd Cardiac Catheterization Laboratory at St. Louis University continues to perform and teach cardiac catheterization and percutaneous coronary interventions. Dr. Kern is ABIM Certified in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology. Dr. Kern is a past president of the Society of Cardiac Angiography and Intervention, and continues to serve many national and international cardiovascular societies. He holds fellowships in the American College of Cardiology, American Heart Association, and Society for Cardiovascular Angiography and Intervention, which bestowed the designation of Master Fellow in 2014. He is an instructor for the annual ACCF/SCAI Interventional Cardiology Board Review program and other National and International Scientific Symposia. In addition to his research interests in coronary blood flow, intravascular physiology, intravascular ultrasound, vulnerable plaque and evaluation of cardiovascular hemodynamics, he is the clinical editor of The Cath Lab Digest, a monthly publication about cardiac catheterization. He has authored several major textbooks, one of which is the leading book on cardiac catheterization, entitled “The Cardiac Catheterization Handbook” now in its 6th edition and its companion “The Interventional Cardiac Cath Handbook”. These books are among the most widely used textbooks both nationally and internationally to train physicians in the subject.
    • Cardiovascular Disease
    • Interventional Cardiology
    • Clinical Pathology
    • CEO at CVPath Institute
    Michael Joner, MD, is the CEO of the CVPath Institute. He has a distinguished career in cardiovascular medicine, pathology, and technology evaluation. He completed his medical training at the University of Wuerzberg and spent 2004-2006 as a cardiovascular pathology fellow at the CVPath Institute. After returning to Germany, since 2007 Dr. Joner has been Head of the Preclinical Research at the German Heart Center in Munich, where he also completed his interventional cardiology residency. He has been a member of the work group for interventional cardiology for the German Society of Cardiology since 2008 and a member of the European Association of Percutaneous Cardiovascular Interventions since 2009. Dr. Joner is an accomplished scientist and leader with a track record of working with high-growth medical technology companies.
    • Interventional Cardiology
    • Interventional Cardiologist, Cardiovascular Research at Fatebenefratelli Hospital
    Bernardo Cortese, MD, Fellow of the European Society of Cardiology, is an Italian cardiologist. He is senior interventional cardiologist and responsible for Cardiovascular Research at Fatebenefratelli Hospital in Milano, Italy. His skills range among complex coronary and peripheral percutaneous interventions. Among his expertise are the following topics: drug-coated balloons for both coronary and peripheral interventions; biovascular scaffolds (around 200 interventions, 15 publications); bivalirudin in the catheterization laboratory; transradial PCI & PTA; left main PCI; manual thrombectomy; intravascular imaging. He served as Primary Investigator in a number of national & international, spontaneous & sponsorized clinical trials. Among the most recent highly impacted trials, he served as Primary Investigator of North/Centre of Italy for the Matrix trial (NEJM 2015). In the last 5 years he lead the following projects: -Italian Guidelines on Drug-Eluting Balloon angioplasty in the coronary field, endorsed by the Italian Scientific Society of Interventional Cardiology (GISE) (2014). -International Guidelines on Drug-Eluting Balloon angioplasty in the peripheral field (2015). -Organization of the DEB School, a Course aiming at dissemination knowledge around drug-coated balloon angioplasty (2013-ongoing) -Start of a Fellowship Program in Interventional Cardiology at Fatebenefratelli Hospital (2014-ongoing). -Member of the Scientific Committee of the Italian Scientific Society of Interventional Cardiology (GISE) (2014-ongoing). -Organization and Directorship of the First International DCB Course, Milano (2014-ongoing).
    • Cardiovascular Disease
    • Medical Director and Chief of Cardiology, Kerckhoff Heart and Thorax Center at University of Giessen
    Professor Christian Hamm received his medical training at the Universities of Mainz and Hamburg before undertaking research fellowships at the Ischaemic Heart Research Unit, University of Cape Town and in the Department of Cardiology at the University of Hamburg. He accepted the position of Associate Professor in Internal Medicine and Cardiology at the University Hospital in Hamburg in 1989, before becoming Medical Director and Chief of Cardiology at the Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany, in 1999. Since 2011 he is also full Professor of Cardiology and Director of the Medical Clinic I at the University of Giessen, Germany. His major research interests include acute coronary syndrome, cardiac biomarkers, cardiac MRI and CT, and interventional cardiology. He has been the principle investigator for many national and international multicenter clinical trial studies and has published frequently referenced articles in the New England Journal of Medicine, The Lancet and Circulation. Prof. Hamm is member of several German and ESC guideline committees and is Co-Chairman of the 2011 ESC Guidelines for Diagnosis Management of patients with non-ST-elevation Acute Coronary Syndromes. He is in the Editorial Boards of several renowned journals. From 2013-2015 he was the President of the German Cardiac Society.
    • Interventional Cardiology
    • Professor of Department of Cardiovascular Medicine at Kyoto University Graduate School of Medicine
    Takeshi Kimura, MD is a Professor of Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine. Dr. Kimura has served as the principal investigator of several large-scale clinical trials and registries in the field of interventional vascular medicine, and has authored more than 500 manuscripts in the peer-reviewed literature. Dr. Kimura’s area of expertise include interventional therapies of coronary artery disease; drug-eluting-stents and bioresorbable scaffold; left main and complex coronary intervention; acute myocardial infarction; antiplatelet and antithrombotic pharmacotherapies, aortic stenosis; and interventional treatment of aortic aneurysms. Dr. Kimura is devoted to interventional and clinical practice in Kyoto University Hospital and to education of medical students and post-graduate students in Kyoto University Graduate School of Medicine.
    • Interventional Cardiology
    • Professor of Medicine at Columbia University Medical Center
    An internationally recognized interventional cardiologist, Dr. Jeffrey W. Moses Professor of Medicine at Columbia University Medical Center has performed more than 15,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the majority of interventional procedures in the U.S. Most recently in on the Executive Committee of PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the U.S. He currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY Dr. Moses is a Associate Director of the Transcatheter Cardiovascular Therapeutics (TCT) conference, the world’s largest interventional cardiology conference. He serves on the Board of the Cardiovascular Research Foundation in New York City; and he has made important contributions in the areas of clinical research and educational activities in interventional vascular therapy. He is also a pioneer in developing approaches involving minimally invasive surgery, angioplasty, gene therapy, novel imaging technologies and various support devices that allow for wider application of interventional cardiovascular procedures. Dr. Moses, who previously held a professorship in Clinical Medicine at New York University School of Medicine, also served in various positions at The New York Hospital (now New York-Presbyterian/Weill Cornell) in New York, where he became Associate Director of the Adult Cardiac Catheterization Laboratory and Director of Clinical Electrophysiology. He is a fellow in multiple professional societies and serves on the editorial board as a reviewer for numerous peer review journals. Dr. Moses completed medical school at the University Of Pennsylvania School Of Medicine and his internship, residency and fellowship in Cardiology at the Presbyterian University of Pennsylvania Medical Center.
    • Regulatory Submissions
    • Medical Devices
    • Product development
    • Biomaterials
    • Polymer science
    Former Abbott Vascular R&D Leader, Bioresorbable Vascular Scaffold Expert
    Former Abbott Vascular R&D Leader, Bioresorbable Vascular Scaffold Expert
    • Medical Device Consultant at Independent Consultant
    James Oberhauser, Ph.D. led product development of Abbott Vascular’s Absorb™ Bioresorbable Vascular Scaffold (BVS) from 2007-2015. In 2009, he authored the seminal article on the therapy in EuroIntervention and has delivered innumerable presentations on the subject in Europe, India, Japan, Australia, and the United States. In 2012, Dr. Oberhauser was honored with the Abbott Vascular President’s Award, and in 2013, he was the recipient of the Innovation Team Award from the Abbott Laboratories Volwiler Society, one of the highest scientific honors bestowed by the company. Dr. Oberhauser holds 24 issued patents and 34 additional pending patent applications and has authored 21 peer-reviewed journal publications. Dr. Oberhauser received his B.S. from the University of California, Davis (1992), M.S. from Stanford University (1993), and Ph.D. from the University of California, Santa Barbara (2001), all degrees in chemical engineering. His dissertation work focused on polymer rheology in the nonlinear viscoelastic flows characteristic of industrial polymer processing. Subsequently, Dr. Oberhauser performed postdoctoral research on flow-induced polymer crystallization at the California Institute of Technology. In 2001, he joined the faculty of the Department of Chemical Engineering at the University of Virginia, where his research interests remained strongly influenced by polymer processing applications but expanded into nanostructured polymeric fluids. Dr. Oberhauser received a National Science Foundation CAREER Award in 2002 and generated over $1 million in individual research funding through successful grant proposals
    • Interventional Cardiology
    CEO of AccelLAB; Assistant Professor Of Medicine, University Of Montreal
    CEO of AccelLAB; Assistant Professor Of Medicine, University Of Montreal
    • Interventional Cardiologist at Centre Hospitalier de l’Université de Montreal
    Guy Leclerc MD FACC is a Cardiologist specialized in cardiovascular research and interventional cardiology at the Centre Hospitalier de l’Université de Montreal, the largest hospital in Quebec. He is an Assistant Professor of Medicine at the University of Montreal. He has authored more than 100 manuscripts and abstracts published in peer-reviewed journals. Dr. Leclerc’s expertise has been focused on preclinical research and the evaluation of cardiovascular medical devices. Trained for three years as a post-doctoral research Fellow with Dr. Jeffrey Isner in Boston, he then established his research laboratory at the CHUM. In 2004 he founded a preclinical contract research organization, AccelLAB, which has become in the past 11 years a world leading CRO in the field of cardiovascular medical devices. His group of 90 scientists and technicians have in the past 4 years devoted a tremendous amount of energy in the evaluation at the preclinical level of resorbable implants including vascular scaffolds, both made of plastic or metal alloys. Dr. Leclerc shares his professional time between clinical interventional cardiology at CHUM and serving as the CEO of AccelLAB Inc. to better evaluate the safety and efficacy of the newest cardiovascular implants.
    • Interventional Cardiology
    • Professor of Medicine, Dept of Cardiology at Mount Sinai Hospital
    Dr. Samin K. Sharma is well known for performing maximum number of complex coronary interventions in the country with highest success rates while achieving an extremely low complication rate. According to New York State Department of Health reports (1994-2002, 2006-2008), he has the highest angioplasty success rate and lowest mortality
    • Interventional Cardiology
    Dr. Bangalore is the PI of a multicenter, international, randomized controlled trial conducted to define the role of an invasive approach in patients with stable ischemic heart disease and substantial ischemia and chronic kidney disease (eGFR
    • Interventional Cardiology
    Interventional Cardiology and Endovascular Specialist, Asst. Prof of Medicine Albert Einstein College of Medicine
    Interventional Cardiology and Endovascular Specialist, Asst. Prof of Medicine Albert Einstein College of Medicine
    Amit M. Kakkar, MD, has trained in prestigious institutions across the country. He first earned his medical degree at the Morehouse School of Medicine, then proceeded to complete a residency in Internal Medicine at Georgetown University Hospital in Washington, DC. With his keen interest in cardiology, he accepted and completed a subspecialty fellowship in Cardiology at Rush University Medical Center in Chicago, IL. Advanced training was then pursued in interventional cardiology procedures at Brown University/The Miriam Hospital in Providence, RI. He recently completed a Vascular Medicine and Endovascular Intervention fellowship at Montefiore Medical Center and Jacobi Medical Center in NY in 2014. He has remained on staff as an attending cardiologist at Jacobi Medical Center and Montefiore Medical Center. He holds board certifications in Internal Medicine and Cardiology. His research has been published in peer reviewed journals and currently he is investigating catheter directed therapies for thromboembolic disease.
    • Interventional Cardiology
    Executive Director and Chief Scientific Officer of the CRF Skirball Research Center
    Executive Director and Chief Scientific Officer of the CRF Skirball Research Center
    • Assistant Professor of Medicine, Division of Cardiology at Columbia University Medical Center
    Juan F. Granada, MD, FACC, is Assistant Professor of Medicine at the Columbia University Medical Center and the Executive Director of the CRF-Skirball Center for Innovation at the Cardiovascular Research Foundation in New York, NY. Dr. Granada is one of the world’s foremost investigators in the field of translational research involving advanced experimental methodologies, endovascular imaging and emerging cardiovascular therapies. Dr. Granada has been involved in the development and validation process of multiple endovascular imaging and cardiovascular device technologies currently in clinical use worldwide. Dr. Granada is a clinically active innovator closely currently leading multiple first-in-human clinical studies involving several emerging cardiovascular technologies. Dr. Granada's areas of expertise include drug-eluting stents and bioresorbable scaffolds; transcatheter mitral valve repair and replacement; intravascular imaging (IVUS, OCT and NIRS); vulnerable plaque diagnosis and treatment; new device angioplasty including atherectomy, distal embolic protection, thrombectomy, covered stents, chronic total occlusion devices, and brachytherapy; saphenous vein graft therapies; left atrial appendage closure; and translational-regulatory pathways. Dr. Granada is co-director of Transcatheter Cardiovascular Therapeutics (TCT), the world's largest symposium devoted to interventional cardiology and vascular medicine and is an active participant and program developer of several academic meetings around the world, including CIT (China Interventional Therapeutics in Beijing, China), TCTAP (TCT Asia Pacific in Seoul, S. Korea), JIM (Joint Interventional Course in Italy), Innovation in Cardiovascular Interventions (ICI), SOLACI (Latin America Society of Interventional Cardiology) and TCT Russia (in Moscow). Dr. Granada completed his cardiovascular disease and interventional cardiology fellowships at Baylor College of Medicine in Houston, Texas. He joined the Cardiovascular Research Foundation in 2007 from The Methodist Hospital Research Institute in Houston, Texas.